Inhibition of LPS-induced iNOS, COX-2 and inflammatory mediator expression by paeonol through the MAPKs inactivation in RAW 264.7 cells

Am J Chin Med. 2009;37(1):181-94. doi: 10.1142/S0192415X0900676X.

Abstract

We evaluated the in vivo anti-inflammatory and analgesic activities of orally administered paeonol in mice, and also investigated the anti-inflammatory activity of paeonol in a cell line. Paeonol significantly reduced the edema induced by arachidonic acid in rats. The analgesic effects were assayed using 2 different models, i.e., by acetic acid-induced writhing response and by formalin induced licking and biting time. Moreover, we examined the effects of paeonol on the release of inflammatory mediators such as NO, PGE(2) and IL-6. Our results demonstrated that paeonol inhibited LPS induced expression of NO, PGE(2) and IL-6. Paeonol prevented LPS induced iNOS, COX-2 and ERK activation. Therefore, paeonol appears to have potential as a treatment for inflammatory disease and analgesic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetophenones / pharmacology*
  • Acetophenones / therapeutic use
  • Analgesics / pharmacology*
  • Analgesics / therapeutic use
  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Cell Survival
  • Cyclooxygenase 2 / metabolism
  • Cynanchum*
  • Dinoprostone / metabolism
  • Edema / chemically induced
  • Edema / drug therapy
  • Interleukin-6 / metabolism
  • Lipopolysaccharides
  • Male
  • Mice
  • Mice, Inbred ICR
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors*
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Pain / drug therapy
  • Phytotherapy
  • Plant Extracts / pharmacology*
  • Plant Roots
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Acetophenones
  • Analgesics
  • Anti-Inflammatory Agents
  • Interleukin-6
  • Lipopolysaccharides
  • Plant Extracts
  • Nitric Oxide
  • paeonol
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • Mitogen-Activated Protein Kinases
  • Dinoprostone